ICH E6(R3) Is Here: How Should You Handle It?

ICH E6(R3) is raising the bar for clinical oversight, data integrity, and sponsor accountability, while biotechs remain under pressure to move quickly and conserve capital. Explore how modern trial operations can meet evolving regulatory expectations through centralized oversight, integrated data workflows, and proactive data management.

By unifying eConsent, eCOA, and EDC into a single audit-ready environment, sponsors can improve visibility, reduce operational burden, and maintain compliance with stricter ALCOA+ and monitoring requirements. Castor highlights how streamlined study setup, real-time risk monitoring, and participant-friendly technology can accelerate timelines, support cleaner datasets, and help emerging biotechs stay inspection-ready without adding unnecessary complexity or cost.